Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 4
1990 2
1991 3
1992 1
1993 8
1994 4
1995 4
1996 8
1997 6
1998 7
1999 12
2000 22
2001 19
2002 13
2003 23
2004 21
2005 17
2006 14
2007 25
2008 18
2009 16
2010 20
2011 21
2012 15
2013 18
2014 14
2015 9
2016 11
2017 11
2018 10
2019 9
2020 13
2021 9
Text availability
Article attribute
Article type
Publication date

Search Results

380 results
Results by year
Filters applied: . Clear all
Page 1
Familial hypercholesterolaemia.
Defesche JC, Gidding SS, Harada-Shiba M, Hegele RA, Santos RD, Wierzbicki AS. Defesche JC, et al. Among authors: wierzbicki as. Nat Rev Dis Primers. 2017 Dec 7;3:17093. doi: 10.1038/nrdp.2017.93. Nat Rev Dis Primers. 2017. PMID: 29219151 Review.
The Agenda for Familial Hypercholesterolemia: A Scientific Statement From the American Heart Association.
Gidding SS, Champagne MA, de Ferranti SD, Defesche J, Ito MK, Knowles JW, McCrindle B, Raal F, Rader D, Santos RD, Lopes-Virella M, Watts GF, Wierzbicki AS; American Heart Association Atherosclerosis, Hypertension, and Obesity in Young Committee of Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and Council on Lifestyle and Cardiometabolic Health. Gidding SS, et al. Among authors: wierzbicki as. Circulation. 2015 Dec 1;132(22):2167-92. doi: 10.1161/CIR.0000000000000297. Epub 2015 Oct 28. Circulation. 2015. PMID: 26510694 Review. No abstract available.
SPRINT: Running into trouble?
Wierzbicki AS. Wierzbicki AS. Int J Clin Pract. 2020 Mar;74(3):e13468. doi: 10.1111/ijcp.13468. Int J Clin Pract. 2020. PMID: 32100458 No abstract available.
Atorvastatin.
Wierzbicki AS. Wierzbicki AS. Expert Opin Pharmacother. 2001 May;2(5):819-30. doi: 10.1517/14656566.2.5.819. Expert Opin Pharmacother. 2001. PMID: 11336625 Review.
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation.
Watts GF, Gidding S, Wierzbicki AS, Toth PP, Alonso R, Brown WV, Bruckert E, Defesche J, Lin KK, Livingston M, Mata P, Parhofer KG, Raal FJ, Santos RD, Sijbrands EJ, Simpson WG, Sullivan DR, Susekov AV, Tomlinson B, Wiegman A, Yamashita S, Kastelein JJ. Watts GF, et al. Among authors: wierzbicki as. Int J Cardiol. 2014 Feb 15;171(3):309-25. doi: 10.1016/j.ijcard.2013.11.025. Epub 2013 Nov 20. Int J Cardiol. 2014. PMID: 24418289 Free article. Review.
Genetic risk scores in lipid disorders.
Wierzbicki AS, Reynolds TM. Wierzbicki AS, et al. Curr Opin Cardiol. 2019 Jul;34(4):406-412. doi: 10.1097/HCO.0000000000000623. Curr Opin Cardiol. 2019. PMID: 31169601 Review.
Low cholesterol syndrome and drug development.
Handhle A, Viljoen A, Ramachandran R, Wierzbicki AS. Handhle A, et al. Among authors: wierzbicki as. Curr Opin Cardiol. 2020 Jul;35(4):423-427. doi: 10.1097/HCO.0000000000000745. Curr Opin Cardiol. 2020. PMID: 32452920 Review.
Lipid-lowering agents.
Ewang-Emukowhate M, Wierzbicki AS. Ewang-Emukowhate M, et al. Among authors: wierzbicki as. J Cardiovasc Pharmacol Ther. 2013 Sep;18(5):401-11. doi: 10.1177/1074248413492906. Epub 2013 Jun 27. J Cardiovasc Pharmacol Ther. 2013. PMID: 23811423 Review.
380 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page